S100B Serum Levels in Chronic Heart Failure Patients: A Multifaceted Biomarker Linking Cardiac and Cognitive Dysfunction
International Journal of Molecular Sciences · 22.08.2024 · 25 (16) · 9094
DOI: 10.3390/ijms25169094 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 22.08.2024. Verfasst von Jan Traub und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine I, University Hospital Würzburg, 97080 Würzburg, Germany. Hauptthemen laut MEDLINE: S100 Calcium Binding Protein beta Subunit, Heart Failure, Biomarkers, Cognitive Dysfunction. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Federal Ministry of Education and Research, Deutsche Forschungsgemeinschaft, Bundesministerium für Bildung und Forschung.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
S100 calcium-binding protein B (S100B) is a protein primarily known as a biomarker for central nervous system (CNS) injuries, reflecting blood–brain barrier (BBB) permeability and dysfunction. Recently, S100B has also been implicated in cardiovascular diseases, including heart failure (HF). Thus, we investigated serum levels of S100B in 146 chronic HF patients from the Cognition.Matters-HF study and their association with cardiac and cognitive dysfunction. The median S100B level was 33 pg/mL (IQR: 22–47 pg/mL). Higher S100B levels were linked to longer HF duration (p = 0.014) and increased left atrial volume index (p = 0.041), but also with a higher prevalence of mild cognitive impairment (p = 0.023) and lower visual/verbal memory scores (p = 0.006). In a multivariable model, NT-proBNP levels independently predicted S100B (T-value = 2.27, p = 0.026). S100B did not impact mortality (univariable HR (95% CI) 1.00 (0.99–1.01); p = 0.517; multivariable HR (95% CI) 1.01 (1.00–1.03); p = 0.142), likely due to its reflection of acute injury rather than long-term outcomes and the mild HF phenotype in our cohort. These findings underscore S100B’s value in comprehensive disease assessment, reflecting both cardiac dysfunction and potentially related BBB disruption.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine I, University Hospital Würzburg, 97080 Würzburg, Germany.
- German Comprehensive Heart Failure Center, University Hospital Würzburg, 97087 Würzburg, Germany.
- Department of Neurology, University Hospital Würzburg, 97080 Würzburg, Germany.
- Department of Psychiatry, Psychosomatics and Psychotherapy, University Hospital Würzburg, 97080 Würzburg, Germany.
ORCID-Profile: Jan Traub, Stefan Störk, Guido Stoll, Anna Frey
Förderung
- Federal Ministry of Education and Research
- Deutsche Forschungsgemeinschaft
- Bundesministerium für Bildung und Forschung
- German Research Foundation
- Interdisziplinäres Zentrum für Klinische Forschung (IZKF) Wuerzburg
Zitieren
APA
Traub, J., Schuhmann, M. K., Sell, R., Frantz, S., Störk, S., Stoll, G., & Frey, A. (2024). S100B Serum Levels in Chronic Heart Failure Patients: A Multifaceted Biomarker Linking Cardiac and Cognitive Dysfunction. International Journal of Molecular Sciences, 25(16), 9094. https://doi.org/10.3390/ijms25169094
Vancouver
Traub J, Schuhmann MK, Sell R, Frantz S, Störk S, Stoll G, et al. S100B Serum Levels in Chronic Heart Failure Patients: A Multifaceted Biomarker Linking Cardiac and Cognitive Dysfunction. International Journal of Molecular Sciences. 2024;25(16):9094. doi:10.3390/ijms25169094
BibTeX
@article{Traub2024,
author = {Traub, Jan and Schuhmann, Michael K and Sell, Roxanne and Frantz, Stefan and Störk, Stefan and Stoll, Guido and Frey, Anna},
title = {S100B Serum Levels in Chronic Heart Failure Patients: A Multifaceted Biomarker Linking Cardiac and Cognitive Dysfunction},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {16},
pages = {9094},
doi = {10.3390/ijms25169094}
}
EUVIMED